SCHEMBL9384284

SCHEMBL9384284

NC(=O)c1nc2c([nH]1)C(=O)CCC2=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.33
▸ MAPK14 Q16539 3/20 0.33
▸ TGFBR1 P36897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10842137 0.75 GSK3B (0.34) GSK3BMAPK14TGFBR1
SCHEMBL10841152 0.65 PARP1 (0.38) GSK3BMAPK14
SCHEMBL10841167 0.64 PARP1 (0.38) GSK3BMAPK14
SCHEMBL15769086 0.61 LMNA (0.65) —
SCHEMBL3230029 0.59 CYP3A4 (0.57) —
SCHEMBL14091342 0.58 PDPK1 (0.36) —
SCHEMBL4455585 0.58 PDPK1 (0.31) —
SCHEMBL11184996 0.57 SCN9A (0.38) —
SCHEMBL3216284 0.57 GAA (0.50) —
SCHEMBL6555062 0.56 MAPT (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0594602-A1 TOPICALLY ACTIVE OCULAR THIADIAZOLE SULFONAMIDE CARBONIC ANHYDRASE INHIBITORS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-05-04 — — EP disclosed
US-5242937-A Treatment of glycoma and assesment of corneal function RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-09-07 — — US disclosed
EP-0594602-A4 TOPICALLY ACTIVE OCULAR THIADIAZOLE SULFONAMIDE CARBONIC ANHYDRASE INHIBITORS. RES CORP TECHNOLOGIES INC (US) 1993-06-16 — — EP disclosed
WO-1991014430-A1 TOPICALLY ACTIVE OCULAR THIADIAZOLE SULFONAMIDE CARBONIC ANHYDRASE INHIBITORS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1991-10-03 — — WO disclosed
Send feedback